NCT02287402View on ClinicalTrials.gov

Postmarketing Clinical Study on AO-128

PHASE4CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Impaired Glucose Tolerance (IGT)
Interventions
DRUG

AO-128

AO-128 tablet

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY